Skip to main content
Figure 1 | BMC Cardiovascular Disorders

Figure 1

From: Plasma calprotectin and its association with cardiovascular disease manifestations, obesity and the metabolic syndrome in type 2 diabetes mellitus patients

Figure 1

Relative increase/decrease of BMI, fasting C-peptide, fasting insulin, HDL cholesterol, HOMA-IR and hs-CRP across calprotectin quartiles. The difference across quartiles were significant at the p < 0.0001 (ANOVA) level for BMI and hs-CRP and at the p < 0.05 level (ANOVA) for fasting C-peptide, fasting insulin, HDL and HOMA-IR (ANOVA).

Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us